Integrity Capital Management (HK)’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Integrity Capital Management (HK)’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-38,428	Closed	-$3K	–	17
2022 Q2	$3K	Sell	38,428 -14,997	-28%	-$2.59K	4.69%	8
2022 Q1	$11K	Sell	53,425 -24,076	-31%	-$7.23K	0.06%	115
2021 Q4	$42K	Buy	+77,501	New	+$43.9K	0.13%	136

Other funds holding IBER.WS

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

DMKJ

David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return

Integrity Capital Management (HK)'s IBER.WS Position: Q3 2022 in Review

Integrity Capital Management (HK) sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q3 2022, closing a stake of 38,428 shares — an estimated $3K sold.

Integrity Capital Management (HK) first reported a position in IBER.WS in Q4 2021 and held it in 3 quarters. The position peaked at $42K in Q4 2021. 38 funds tracked by Wall St. Rank hold IBER.WS as of Q3 2022.

Integrity Capital Management (HK) reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q3 2022 after selling out during the quarter.
Integrity Capital Management (HK) sold 38,428 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q3 2022, an estimated $3K.
Integrity Capital Management (HK) first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q4 2021 and held it in 3 quarters.
Integrity Capital Management (HK)'s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $42K in Q4 2021.
38 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q3 2022.

Based on Integrity Capital Management (HK)'s 13F filing for Q3 2022.